December OGD Metrics Updated

The Office of Generic Drugs (OGD) updated its December 2019 (first quarter FY 2020) statistics with metrics, in addition to the approvals, receipts of original ANDAs, and complete response letters that were published a few weeks ago.

The OGD reported refusing-to-receive (RTR) four ANDAs, three standard review and one priority review application.  While four is the highest number of RTRs issued this FY (the first two months had one and three),